Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors.

Jennifer M King Michael ChengKenneth KeslerRyan AshkarSandra K AlthouseNasser H HannaLawrence H EinhornNabil Adra

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

The presence of teratoma in the primary tumor site is associated with a higher rate of teratoma in postchemotherapy residual non-RP disease. Patients without teratoma in the primary tumor should still be considered for resection of residual postchemotherapy disease that could harbor teratoma or active germ-cell tumor.

Keyphrases

germ cell
end stage renal disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes